- Home
- ANGH vs RANI Comparison
ANGH vs RANI Comparison
Compare ANGH & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- RANI
- Stock Information
- Founded
- ANGH 2012
- RANI 2012
- Country
- ANGH United Arab Emirates
- RANI United States
- Employees
- ANGH N/A
- RANI N/A
- Industry
- ANGH Telecommunications Equipment
- RANI Medicinal Chemicals and Botanical Products
- Sector
- ANGH Consumer Discretionary
- RANI Health Care
- Exchange
- ANGH Nasdaq
- RANI Nasdaq
- Market Cap
- ANGH 47.5M
- RANI 55.3M
- IPO Year
- ANGH N/A
- RANI 2021
- Fundamental
- Price
- ANGH $0.67
- RANI $1.27
- Analyst Decision
- ANGH
- RANI Strong Buy
- Analyst Count
- ANGH 0
- RANI 6
- Target Price
- ANGH N/A
- RANI $11.33
- AVG Volume (30 Days)
- ANGH 27.0K
- RANI 147.7K
- Earning Date
- ANGH 04-11-2025
- RANI 05-05-2025
- Dividend Yield
- ANGH N/A
- RANI N/A
- EPS Growth
- ANGH N/A
- RANI N/A
- EPS
- ANGH N/A
- RANI N/A
- Revenue
- ANGH $52,274,011.00
- RANI N/A
- Revenue This Year
- ANGH N/A
- RANI N/A
- Revenue Next Year
- ANGH N/A
- RANI N/A
- P/E Ratio
- ANGH N/A
- RANI N/A
- Revenue Growth
- ANGH 13.03
- RANI N/A
- 52 Week Low
- ANGH $0.61
- RANI $1.24
- 52 Week High
- ANGH $2.27
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- ANGH 45.48
- RANI 37.10
- Support Level
- ANGH $0.62
- RANI $1.30
- Resistance Level
- ANGH $0.76
- RANI $1.56
- Average True Range (ATR)
- ANGH 0.06
- RANI 0.09
- MACD
- ANGH 0.00
- RANI -0.02
- Stochastic Oscillator
- ANGH 37.53
- RANI 16.06
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with the catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner and is continuously licensing new content.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.